1 |
Kim TH, Kim YK, Kwon Y, et al (2010). Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology, 57, 734-43.
DOI
ScienceOn
|
2 |
Lages E, Ipas H, Guttin A, et al (2012). MicroRNAs: molecular features and role in cancer. Front Biosci, 17, 2508-40.
DOI
|
3 |
Lee S, and Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126.
DOI
ScienceOn
|
4 |
Li S, Meng H, Zhou F, et al (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract, 209, 179-83.
DOI
ScienceOn
|
5 |
Lodes MJ, Caraballo M, Suciu D, et al (2009). Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray. PLoS One, 4, 6229.
DOI
ScienceOn
|
6 |
Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep, 1, 71-9.
DOI
ScienceOn
|
7 |
Selcuklu SD, Donoghue MT, Rehmet K, et al (2012). MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. J Biol Chem, 287, 29516-28.
DOI
|
8 |
Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
DOI
ScienceOn
|
9 |
Singh R, Mo YY (2013). Role of microRNAs in breast cancer. Cancer Biol Ther, 14, 201-12.
DOI
ScienceOn
|
10 |
Tang J, Ahmad A, Sarkar FH (2012). The role of MicroRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci, 13, 13414-37.
DOI
ScienceOn
|
11 |
Wang QY, Tang J, Zhou CX, et al (2012). The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility. Sheng Li Xue Bao, 64, 403-11.
|
12 |
Yang H, Cho ME, Li TWH, et al (2013). MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest. 123, 285-298.
DOI
ScienceOn
|
13 |
Yang L, Sun TT, Wang N (2012). The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi, 46, 1009-14.
|
14 |
Zhou J, Tian Y, Li J, et al (2013). miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Biochem Biophys Res Commun, 433, 207-12.
DOI
ScienceOn
|
15 |
Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, et al (2012). miR-10b*, a master inhibitor of the cell cycle, is downregulated in human breast tumours. EMBO Mol Med, 4, 1214-29.
DOI
|
16 |
Costa FF, Jared M, Bischof JM, et al (2011). Identification of MicroRNAs as potential prognostic markers in ependymoma. PLoS One, 6, 25114.
DOI
|
17 |
Fils-Aime N, Dai M, Guo J, et al (2013). MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a new signaling route through which transforming growth factor- mediates the migration and actin dynamics of breast cancer cells. J Biol Chem, 288, 11807-23.
DOI
ScienceOn
|
18 |
Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8.
과학기술학회마을
DOI
ScienceOn
|
19 |
Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark, 11, 269-80.
|
20 |
Hu X, Guo J, Zheng L, et al (2013). The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Molec Cancer Res, 11, 240-50.
DOI
ScienceOn
|
21 |
Chen CF, He X, Arslan AD, et al (2011). Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase and drug responsiveness. Mol Pharmacol, 79, 735-41.
DOI
ScienceOn
|
22 |
Imam JS, Plyler JR, Bansal H, et al (2012). Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS One, 7, 52397.
DOI
|
23 |
Kala R, Peek GW, Hardy TM, et al (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinform, 16, 6-13.
|